NasdaqCM - Nasdaq Real Time Price USD

Heart Test Laboratories, Inc. (HSCS)

0.0990 -0.0009 (-0.90%)
As of 11:15 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2023
4/30/2022
4/30/2021
4/30/2020
Total Revenue
18.6000
5.1500
14.3730
25.6040
64.1820
Cost of Revenue
6.0810
2.7960
7.8900
10.6650
46.4600
Gross Profit
12.5190
2.3540
6.4830
14.9390
17.7220
Operating Expense
6,037.1580
6,115.3180
4,715.8820
2,583.0670
3,835.9060
Operating Income
-6,024.6390
-6,112.9640
-4,709.3990
-2,568.1280
-3,818.1840
Net Non Operating Interest Income Expense
-367.1000
-243.1740
-371.6190
-132.4540
-2.8110
Other Income Expense
0.3340
1.8480
252.7580
248.4120
9.8770
Pretax Income
-6,391.4050
-6,354.2900
-4,828.2600
-2,452.1700
-3,811.1180
Net Income Common Stockholders
-6,391.4050
-6,354.2900
-4,828.2600
-2,452.1700
-3,811.1180
Diluted NI Available to Com Stockholders
-6,391.4050
-6,354.2900
-4,828.2600
-2,452.1700
-3,811.1180
Basic EPS
-0.35
-0.80
-0.60
-0.30
-0.47
Diluted EPS
-0.35
-0.80
-0.60
-0.30
-0.47
Basic Average Shares
21,322.4950
7,950.5500
8,112.1990
8,042.3300
8,042.3300
Diluted Average Shares
21,322.4950
7,950.5500
8,112.1990
8,042.3300
8,042.3300
Total Operating Income as Reported
-6,024.6390
-6,112.9640
-4,709.3990
-2,566.4650
-3,828.2000
Total Expenses
6,043.2390
6,118.1140
4,723.7720
2,593.7320
3,882.3660
Net Income from Continuing & Discontinued Operation
-6,391.4050
-6,354.2900
-4,828.2600
-2,452.1700
-3,811.1180
Normalized Income
-6,391.4050
-6,354.2900
-5,078.4600
-2,704.0330
-3,801.1020
Interest Expense
367.1000
243.1740
371.6190
132.4540
2.8110
Net Interest Income
-367.1000
-243.1740
-371.6190
-132.4540
-2.8110
EBIT
-6,024.3050
-6,111.1160
-4,456.6410
-2,319.7160
-3,808.3070
EBITDA
-5,998.7890
-6,084.2010
-4,430.0750
-2,286.1050
-3,744.4800
Reconciled Cost of Revenue
6.0810
2.7960
7.8900
10.6650
46.4600
Reconciled Depreciation
25.5160
26.9150
26.5660
33.6110
63.8270
Net Income from Continuing Operation Net Minority Interest
-6,391.4050
-6,354.2900
-4,828.2600
-2,452.1700
-3,811.1180
Total Unusual Items Excluding Goodwill
--
--
250.2000
251.8630
-10.0160
Total Unusual Items
--
--
250.2000
251.8630
-10.0160
Normalized EBITDA
-5,998.7890
-6,084.2010
-4,680.2750
-2,537.9680
-3,734.4640
4/30/2020 - 6/16/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SINT Sintx Technologies, Inc.
0.0388
+6.01%
 
NUWE Nuwellis, Inc.
0.1696
-41.31%
 
RSLS ReShape Lifesciences Inc.
0.1800
+1.12%
 
DYNT Dynatronics Corporation
0.5319
-7.53%
 
BIOL BIOLASE, Inc.
0.1430
-3.38%
 
INVO INVO Bioscience, Inc.
0.9601
-2.04%
 
VTAK Catheter Precision, Inc.
0.5445
-1.00%
 
INBS Intelligent Bio Solutions Inc.
2.6419
+6.10%
 
BSGM BioSig Technologies, Inc.
1.3781
+6.01%
 
TBIO Telesis Bio, Inc.
0.3142
-5.16%